Explore the words cloud of the DIAGORAS project. It provides you a very rough idea of what is the project "DIAGORAS" about.
The following table provides information about the project.
HAHN-SCHICKARD-GESELLSCHAFT FUER ANGEWANDTE FORSCHUNG E.v.
|Coordinator Country||Germany [DE]|
|Total cost||5˙588˙101 €|
|EC max contribution||4˙721˙198 € (84%)|
1. H2020-EU.3.1.3. (Treating and managing disease)
|Duration (year-month-day)||from 2015-06-01 to 2019-05-31|
Take a look of project's partnership.
|1||HAHN-SCHICKARD-GESELLSCHAFT FUER ANGEWANDTE FORSCHUNG E.v.||DE (Villingen)||coordinator||985˙378.00|
|2||ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM||NL (ROTTERDAM)||participant||819˙016.00|
|3||AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH||AT (WIEN)||participant||749˙531.00|
|4||BIOVENDOR - LABORATORNI MEDICINA AS||CZ (BRNO)||participant||625˙308.00|
|5||Askion GmbH||DE (GERA)||participant||499˙250.00|
|6||CLINICAGENO LIMITED||UK (COULSDON SURREY)||participant||436˙208.00|
|7||MAGNAMEDICS DIAGNOSTICS BV||NL (GELEEN)||participant||398˙317.00|
|8||SPARKS & CO||FR (PARIS)||participant||121˙563.00|
|9||MAGTIVIO B.V.||NL (Heerlen)||participant||70˙432.00|
|10||KAROLINSKA INSTITUTET||SE (STOCKHOLM)||participant||16˙191.00|
|11||UNIVERSITAT ZURICH||CH (ZURICH)||participant||0.00|
The project aims at diagnosing oral and respiratory tract infections (RTIs) using a fully integrated, automated and user-friendly platform for physicians’ offices, schools, elderly care units, community settings, etc. Oral diseases (periodontitis, caries) will be detected via multiplexed, quantitative analysis of salivary markers (bacterial DNA and host response proteins) for early prevention and personalized monitoring. RTIs (e.g., tonsillitis, pharyngitis, rhinitis, sinusitis) will be diagnosed by means of DNA/RNA differentiation so as to identify their bacterial vs viral nature. Together with antibiotic resistance screening on the same platform, a more efficient treatment management is expected at the point-of-care. High impact is expected on socioeconomic level too, as the healthcare system is expected to benefit from: less crowded hospitals (patients find equally efficient chair-side diagnosis); less budget spent on excessive antibiotics and progressed-stage disease treatments; less insurance costs for oral diseases, which are largely age-related. At the heart of DIAGORAS lies a centrifugal microfluidic platform (LabDisk and associated reader) integrating all components and assays for a fully-automated analysis: interface of the collection tube with the disposable disc; on-disc sample preparation (nucleic acid extraction and purification with pre-stored buffers); amplification & detection (rapid PCR); protein isolation and detection (bead-based multiplexed immunoassays); microarray-based antibiotic screening. Low-cost disposable fabrication (microthermoforming of polymer foils) will render the platform batch-producible and affordable to end users. The entire setup will be validated at clinical settings and compared with gold standards (e.g., tissue extraction and culture methods). The modular nature of the platform, the non-invasive sampling, the rapid and multiplexed molecular-based detection, and the sample-to-answer analysis are DIAGORAS innovative features.
|D9.2 Questionnaires from EMC and UZH(PPC) for clinician, GP, and dentist feedback||Documents, reports||2020-02-26 16:30:53|
|D10.7 Project-related video||Websites, patent fillings, videos etc.||2020-02-26 16:30:53|
|D10.6 Two workshops organised at partners EMC, UZH and KI||Websites, patent fillings, videos etc.||2020-02-26 16:30:53|
|D10.3 Communication materials||Websites, patent fillings, videos etc.||2020-02-26 16:30:52|
|D10.1 Project website and intranet||Websites, patent fillings, videos etc.||2020-02-26 16:30:52|
Take a look to the deliverables list in detail: detailed list of DIAGORAS deliverables.
|year||authors and title||journal||last update|
Alex van Belkum, Till T. Bachmann, Gerd LÃ¼dke, Jan Gorm Lisby, Gunnar Kahlmeter, Allan Mohess, Karsten Becker, John P. Hays, Neil Woodford, Konstantinos Mitsakakis, Jacob Moran-Gilad, Jordi Vila, Harald Peter, John H. Rex, Wm. Michael Dunne
Developmental roadmap for antimicrobial susceptibility testing systems
published pages: 51-62, ISSN: 1740-1526, DOI: 10.1038/s41579-018-0098-9
|Nature Reviews Microbiology 17/1||2020-02-26|
Konstantinos Mitsakakis, Wendy E Kaman, Gijs Elshout, Mara Specht, John P Hays
Challenges in identifying antibiotic resistance targets for point-of-care diagnostics in general practice
published pages: 1157-1164, ISSN: 1746-0913, DOI: 10.2217/fmb-2018-0084
|Future Microbiology 13/10||2020-02-26|
Georgios N. Belibasakis, Michael A. Curtis, George Hajishengallis, Egija Zaura
Meeting report: The 12 th European oral microbiology workshop (EOMW) in Stockholm, Sweden
published pages: 64-69, ISSN: 2150-5594, DOI: 10.1080/21505594.2017.1376147
John P Hays
Why is scientific research on â€˜data-poorâ€™ microorganisms being ignored?
published pages: 645-650, ISSN: 1746-0913, DOI: 10.2217/fmb-2017-0061
|Future Microbiology 12/8||2020-02-26|
Y. Zhao, G. Czilwik, V. Klein, K. Mitsakakis, R. Zengerle, N. Paust
C-reactive protein and interleukin 6 microfluidic immunoassays with on-chip pre-stored reagents and centrifugo-pneumatic liquid control
published pages: 1666-1677, ISSN: 1473-0197, DOI: 10.1039/c7lc00251c
|Lab on a Chip 17/9||2020-02-26|
Wendy E Kaman, Gijs Elshout, Patrick JE Bindels, Konstantinos Mitsakakis, John P Hays
Current problems associated with the microbiological point-of-care testing of respiratory tract infections in primary care
published pages: 607-610, ISSN: 1746-0913, DOI: 10.2217/fmb-2015-0020
|Future Microbiology 11/5||2020-02-26|
Annemiek A van der Eijk, Andrei N Tintu, John P Hays
Pre-implementation guidelines for infectious disease point-of-care testing in medical institutions
published pages: 51-58, ISSN: 1746-0913, DOI: 10.2217/fmb-2016-0120
|Future Microbiology 12/1||2020-02-26|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DIAGORAS" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "DIAGORAS" are provided by the European Opendata Portal: CORDIS opendata.
CeLac and European consortium for a personalized medicine approach to Gastric CancerRead More
PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregiversRead More
ENDOSCAPE, a clinically applicable non-viral gene delivery technologyRead More